Sign up now!
Don't show this again
Sweepstakes Rules

We’re glad you’re enjoying Poultry Health Today.
Access is free but you’ll need to register to view more content.
Already registered? Sign In
Tap to download the app
REPORTSCollect articles and features into your own report to read later, print or share with others

Create a New Report


Read Later

Create a new report

Report title (required) Brief description (optional)
follow us

You must be logged in to edit your profile.

Sponsored by Zoetis

Sponsored By Zoetis

PHTweb Lundeen Reverse Genetics 77369564

‘Reverse genetics’ may offer new IBV vaccine targets

Researchers at The Pirbright Institute in the UK report that a recent study provides evidence that mutations in the genetic code for non-structural proteins “offer a promising way” to make vaccines against infectious bronchitis virus (IBV) safer. Furthermore, they noted these vaccines may also be suitable for in ovo vaccination of chicks prior to hatching.

Better vaccines against IBV could have a significant effect on improving the health and welfare of poultry around the world.

IBV is a gammacoronavirus that causes highly contagious respiratory symptoms in poultry. It can also affect the reproductive tracts of birds.

Current IBV vaccines are typically live-attenuated virus vaccines, created by infecting embryonated hens’ eggs with live virus. This process involves harvesting the virus and then infecting more eggs, so each time the virus is recovered it is weaker and less able to cause disease.

However, this method leaves a risk that the resulting weakened strain could potentially revert to being able to cause disease. Using eggs in this way could also increase the virus’s ability to cause death in chicks before they have hatched.

Vaccinating eggs is easier than vaccinating flocks of chickens, which makes it advantageous to the poultry industry, said Erica Bickerton, PhD, head of the Pirbright coronaviruses group.

By understanding a virus’s genome, researchers can get a better understanding of how it causes disease, which, in turn, can help create more controlled and stable vaccines.

Targeting the genetic code

Published in the Journal of Virology, the Pirbright scientists have identified parts of the IBV genetic code that could be targeted to weaken the virus, such as genetic sequences that control virus multiplication and the ability to cause disease, and start an immune response.

Using a technique called “reverse genetics,” the researchers examined how the genetic code influences virus behavior during infection, which enabled them to then alter the genome of a disease-causing strain of IBV known as M41. Altering these important genetic sequences weakened the virus and prevented it from causing disease, the researchers said.

Pirbright researchers said “non-structural” proteins — proteins involved in virus multiplication or control of the chicken’s cells — were identified as potential targets to weaken the M41 IBV strain.

“The development of this reverse genetics system provides a powerful tool for future in-depth research into IBV’s ability to cause disease and affect the host immune system, as well as vaccine development,” Bickerton said. “The weakened IBV strain generated from this study shows promise as a vaccine strain because the genetic mechanisms of attenuation are proven to be stable, and the ability to cause disease in chickens and eggs is reduced.”



Shareicon Pht 1
Share It
Researchers at The Pirbright Institute in the UK report that a recent study provides evidence that mutations in the genetic code for non-structural proteins “offer a promising way” to make vaccines against infectious bronchitis virus (IBV) safer.

Click an icon to share this information with your industry contacts.

Posted on August 4, 2022

tags: , ,
  • Tooling up for better disease protection through applied research

    Vaccines are powerful, widely used tools for managing poultry diseases. How can the industry keep pace with variant viruses and other challenges?

  • Why ‘vaccinated’ chickens still get infected with IBV — and what to do about it

    While many vaccines and vaccination programs effectively protect against the highly contagious infectious bronchitis virus in poultry, outbreaks of the disease still occur in vaccinated flocks.

  • Zoetis Expands Poultry Portfolio with Poulvac® Procerta® HVT-IBD-ND

    Zoetis has expanded its poultry vaccine portfolio with the introduction of Poulvac® Procerta® HVT-IBD-ND, a recombinant vector vaccine that provides early, robust protection against Marek’s, infectious bursal and Newcastle disease viruses with one dose.

  • Poultry industry can learn from COVID-19

    Biosecurity is not sufficient to control avian coronaviruses like infectious bronchitis in commercial poultry, no matter how good it is, said Mark Jackwood, PhD, a molecular virologist and professor of avian medicine at the University of Georgia.

You must be logged in to edit your profile.

Google Translate is provided on this website as a reference tool. However, Poultry Health Today and its sponsor and affiliates do not guarantee in any way the accuracy of the translated content and are not responsible for any event resulting from the use of the translation provided by Google. By choosing a language other than English from the Google Translate menu, the user agrees to withhold all liability and/or damage that may occur to the user by depending on or using the translation by Google.